Literature DB >> 12628937

Antibiotic treatment of atherosclerotic cardiovascular disease.

J Thomas Grayston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628937     DOI: 10.1161/01.cir.0000056032.56396.89

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

Review 1.  Inflammatory mechanisms of stroke.

Authors:  Mitchell S V Elkind
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Targeting inflammation: impact on atherothrombosis.

Authors:  Maria Giulia Marini; Chiara Sonnino; Marco Previtero; Luigi M Biasucci
Journal:  J Cardiovasc Transl Res       Date:  2013-12-11       Impact factor: 4.132

Review 3.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

Review 4.  Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Authors:  Z Xu; J Li; H Wang; G Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-27       Impact factor: 3.267

Review 5.  Role of gut microbiota in atherosclerosis.

Authors:  Annika Lindskog Jonsson; Fredrik Bäckhed
Journal:  Nat Rev Cardiol       Date:  2016-12-01       Impact factor: 32.419

6.  Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease.

Authors:  Christian Gluud; Bodil Als-Nielsen; Morten Damgaard; Jørgen Fischer Hansen; Stig Hansen; Olav H Helø; Per Hildebrandt; Jørgen Hilden; Gorm Boje Jensen; Jens Kastrup; Hans Jørn Kolmos; Erik Kjøller; Inga Lind; Henrik Nielsen; Lars Petersen; Christian M Jespersen
Journal:  Cardiology       Date:  2008-05-02       Impact factor: 1.869

7.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases.

Authors:  Zhi Song; Paul Brassard; James M Brophy
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

Review 9.  Infectious burden: a new risk factor and treatment target for atherosclerosis.

Authors:  Mitchell S V Elkind
Journal:  Infect Disord Drug Targets       Date:  2010-04

Review 10.  Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Front Cell Infect Microbiol       Date:  2014-03-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.